文献速递脑血管病

真实世界卒中取栓功能结局:德国全国前瞻性登记研究

Functional Outcome Following Stroke Thrombectomy in Clinical Practice.
PubMed 文献 · Stroke · 2019-07-24

成功再灌注率达83%,3个月良好结局(mRS 0-2)为37%,死亡率为29%,前循环与后循环闭塞结局无差异。

要点

  • 真实世界成功再灌注率83%,3个月良好结局37%,死亡率29%。
  • 前循环与后循环闭塞的功能结局无显著差异(P=0.27)。
  • 再灌注成功、使用阿替普酶、低卒中严重度等与良好结局独立相关。

核心结论

  • 全国范围真实世界血管内治疗可获得较高的良好功能结局率,但日常实践中死亡率高于大型随机试验报告。

主要发现

  • 中位年龄75岁(IQR 64-82),中位NIHSS评分15分(IQR 10-19)。
  • 前循环闭塞2265例(88%),后循环闭塞303例(12%)。
  • 血管内治疗前接受静脉阿替普酶1457例(56%)。
  • 成功再灌注2143例(83%);3个月良好结局854例(37%);死亡率29%。
  • 前循环与后循环闭塞结局无差异(P=0.27)。

关键数值与推荐

  • 良好结局的显著预测因素:较年轻年龄(OR 1.06;95%CI 1.05-1.07)、无院间转运(OR 1.39;95%CI 1.03-1.88)、较低卒中严重度(OR 1.10;95%CI 1.08-1.13)、较小梗死体积(OR 1.26;95%CI 1.15-1.39)、使用阿替普酶(OR 1.49;95%CI 1.08-2.06)、再灌注成功(OR 1.69;95%CI 1.45-1.96)。

临床怎么用

  • 真实世界取栓应追求高再灌注率以改善功能结局,同时关注日常实践中较高的死亡率。
  • 前循环与后循环闭塞均可从血管内治疗中获益,结局无显著差异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background and Purpose- Endovascular treatment for large vessel occlusion in ischemic stroke has proven to be effective in large clinical trials. We aimed to provide real-world estimates of endovascular treatment reperfusion rates and functional outcome on a countrywide scale. Methods- Two thousand seven hundred ninety-four patients with large vessel occlusion were included into an investigator-initiated, industry-independent, prospective registry in 25 sites in Germany between June 2015 and April 2018. The primary outcome was the score on the modified Rankin Scale ranging from zero (no symptoms) to 6 (death) at 3 months. Secondary analyses included the prediction of a good outcome (modified Rankin Scale, 0-2). Dichotomized analyses of predictors were performed using logistic regression adjusted for potential confounders. Results- Median age was 75 years (interquartile range, 64-82); median National Institutes of Health Stroke Scale score was 15 (interquartile range, 10-19). Vessel occlusion was in the anterior circulation in 2265 patients (88%) and in the posterior circulation in 303 patients (12%). Intravenous alteplase before endovascular treatment was given in 1457 patients (56%). Successful reperfusion was achieved in 2143 subjects (83%). At 3 months, 854 patients (37%) showed a good outcome; mortality was 29%. There was no difference between anterior and posterior circulation occlusions (P=0.27). Significant predictors for a good outcome were younger age (odds ratio [OR], 1.06; 95% CI, 1.05-1.07), no interhospital transfer (OR, 1.39; 95% CI, 1.03-1.88), lower stroke severity (OR, 1.10; 95% CI, 1.08-1.13), smaller infarct size (OR, 1.26; 95% CI, 1.15-1.39), alteplase use (OR, 1.49; 95% CI, 1.08-2.06), and reperfusion success (OR, 1.69; 95% CI, 1.45-1.96). Conclusions- High rates of favorable outcome can be achieved on a countrywide scale by endovascular treatment. Mortality appears to be greater in the daily routine than otherwise reported by authors of large randomized trials. There were no outcome differences between the anterior and posterior circulation. Clinical Trial Registration- URL: https://www.clinicaltrials.gov. Unique identifier: NCT03356392.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Wollenweber FA, Tiedt S, Alegiani A, et al. Functional Outcome Following Stroke Thrombectomy in Clinical Practice. Stroke. 2019. PMID: 31337298. doi:10.1161/STROKEAHA.119.026005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。